Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/10/2011
PIL Enbrel 25 mg powder and solvent for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to storage instructions
Updated on 23/09/2011 and displayed until 21/10/2011
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 23/08/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 20/07/2011 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 10/06/2011 and displayed until 20/07/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/05/2011 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 07/03/2011 and displayed until 27/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 04/02/2011 and displayed until 07/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 03/02/2011 and displayed until 04/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 22/12/2010 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/07/2010 and displayed until 22/12/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
Updated on 03/06/2010 and displayed until 21/07/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 10/03/2010 and displayed until 03/06/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 22/12/2009 and displayed until 10/03/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 29/07/2009 and displayed until 22/12/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/06/2009 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/04/2009 and displayed until 10/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/01/2009 and displayed until 09/04/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 10/12/2008 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/07/2008 and displayed until 10/12/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to drug interactions
  • Change to date of revision
  • Change to side-effects
Updated on 12/12/2007 and displayed until 29/07/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/09/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to how to administer the medicine
Updated on 01/02/2007 and displayed until 25/09/2007
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 19/12/2006 and displayed until 01/02/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 16/11/2006 and displayed until 19/12/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to Further Information section
  • Change to date of revision
Updated on 10/07/2006 and displayed until 16/11/2006
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 21/09/2005 and displayed until 10/07/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change to how the medicine works
Updated on 09/05/2005 and displayed until 21/09/2005
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to information about driving or using machinery
  • Change to storage instructions
  • Change to Further Information section
  • Change to how to administer the medicine
Updated on 04/11/2004 and displayed until 09/05/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to drug interactions
Updated on 23/09/2004 and displayed until 04/11/2004
Reasons for adding or updating:
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 03/06/2004 and displayed until 23/09/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  etanercept